General description
Benserazide is a peripheral decarboxylase inhibitor.
Application
Benserazide has been used:
- to inhibit dopa-decarboxylase
- to induce dyskinesia
- to test on purified bacterial TDCs to assess the extent to which it could affect bacterial decarboxylases
- as a peripheral dopa decarboxylase inhibitor to treat mice
Biochem/physiol Actions
Benserazide can block HK2 enzymatic activity in vitro. It is used along with levodopa to treat Parkinson′s disease.
Inhibitor of
Features and Benefits
This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 51141590
- Condition:
- New
- Availability:
- 3-5 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- MPN:
- B7283-1G
- CAS:
- 14919-77-8